March 4 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O:
BIOCRYST PHARMACEUTICALS INC - CFO ANTHONY DOYLE TO RESIGN EFFECTIVE APRIL 9, 2025
Source text: [ID:n0001171843-25-001231]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.